Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

G Odintsova

G Odintsova

Almazov National Medical Research Center, Russia

Title: Reproductive behavior in women with epilepsy

Biography

Biography: G Odintsova

Abstract

The significance of epilepsy reproductive questins is provided by medical social aspects of the disease.

Purpose was to research reproductive behaviour (RB) and fertility rate(FR) in women with epilepsy (WWE).

128 WWE aged 20 - 45y.o. were included in the prospective observation research of antiepileptic drugs (AEDs) reproductive side effects. 3 groups were allocated: 1gr. - AEDs monotherapy, 2 gr. - polytherapy, 3 gr. - without AEDs. FR was accounted. RB was investigated by interview.

Results: 1gr. - 58 (45%), 2gr. - 53 (42%), 3 gr. - 16 patients (13%). Average age of the surveyed women made 25 years with prevalence patients in optimal reproductive age (20-30y.o.)- 62%. 47% women were marriage. 31% had children without differences in groups. Only 18% children were born before mother's disease. Fertility rate- is the average number of children that would be born to a woman over her lifetime. Fertility rate for simple generations replacements should be 2, 15. Fertility rate was 0, 3 in cohort. Women planning pregnancies were 45%. Majority patients planned to have one child. New RB tendency was presented by early repeated pregnancies. New generation AEDs (lacosamide, perampanel) allowed achieving remission in first and second polytherapy but weren't resolved in monotherapy. It was real problem for women in reproductive age. RB “without children” remained actual problem for epilepsy.

Conclusion: Reproductive behaviour was changing at the present time. Fertility rate among women with epilepsy was lower optimal due to medical and social reasons.

Antiepileptic therapy during pregnancy remained a legal problem.